- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Respiratory syncytial virus vaccine (bivalent, recombinant) is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- J07BX05 Respiratory syncytial virus vaccine (bivalent, recombinant) · Pfizer–BioNTech COVID-19 vaccine
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Biologic
- Yes
All presentations
No presentations of Respiratory syncytial virus vaccine (bivalent, recombinant) are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Respiratory syncytial virus vaccine (bivalent, recombinant) available for export from India?
No presentation of Respiratory syncytial virus vaccine (bivalent, recombinant) is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Respiratory syncytial virus vaccine (bivalent, recombinant) authorised in the European Union?
Yes. Respiratory syncytial virus vaccine (bivalent, recombinant) has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Respiratory syncytial virus vaccine (bivalent, recombinant) need cold chain shipping?
No listed presentation of Respiratory syncytial virus vaccine (bivalent, recombinant) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Respiratory syncytial virus vaccine (bivalent, recombinant) in?
Respiratory syncytial virus vaccine (bivalent, recombinant) is classified under ATC code J07BX05 (Respiratory syncytial virus vaccine (bivalent, recombinant)).
References
- Abrysvo: European public assessment report (EPAR). European Medicines Agency. Retrieved 14 September 2026
Request Respiratory syncytial virus vaccine (bivalent, recombinant) for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.